Sanofi, Myokardia Team Up to Work on Genetic Heart Disease
September 17 2014 - 1:46AM
Dow Jones News
By Inti Landauro
PARIS--French pharmaceutical giant Sanofi SA (SAN.FR) Wednesday
said it teamed up with closely held Myokardia to develop therapies
for genetic heart diseases, called cardiomyopathies.
The two companies will make as much as $200 million on combined
investment by 2018, Sanofi said.
-Write to Inti Landauro at inti.landauro@wsj.com
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Sanofi (EU:SAN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sanofi (EU:SAN)
Historical Stock Chart
From Apr 2023 to Apr 2024